The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
about
Slow turnover of HIV-1 receptors on quiescent CD4+ T cells causes prolonged surface retention of gp120 immune complexes in vivoDipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.Small molecule inhibitors of CXCR4.Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.Recent progress in antiretrovirals--lessons from resistanceMultimodality imaging of CXCR4 in cancer: current status towards clinical translation.Recent patents regarding the discovery of small molecule CXCR4 antagonists.The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury.Microenvironmental cues for T-cell acute lymphoblastic leukemia development.Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung.CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc.Radiotheranostics in Cancer Diagnosis and Management.Update on the development of HIV entry inhibitors
P2860
Q27330487-8B4F5B16-9074-4AD3-907D-470EDEBDC6DCQ34414241-E23328EB-1DCC-41BF-A09C-9EE252111724Q34574987-43D3AB39-FF52-489F-9E09-4295F7D81C10Q36176102-793D6E56-C7A7-40F6-8E4A-56FD18634593Q36347213-D1D15E1B-16E6-4009-80ED-24C6E41429BCQ36583985-B047B1DC-B308-4B20-9E83-BE0E3EEE7E1AQ36967857-375DB696-575B-4E84-B682-D6DFABABE97EQ37337280-A19622BE-5991-4CA5-BF4D-E27C76D32743Q37481233-558E2394-B552-4D13-A6F3-BC2C81F56F3DQ37728238-2D447DF3-51DC-45EC-97D3-3CF881BA5806Q38810904-ED7797A3-C170-4E45-A3AD-B3EF67BA953CQ40051508-63C67410-A444-414C-8C64-637B0481BAA9Q40439589-21ACB4A0-2266-4FE1-81E8-037CAC4CD495Q45807906-AB2A77E5-E9FA-4309-83F3-C9B068EA668FQ47719762-ED99CB6B-4B85-4251-BD61-2A0DE5B575E7Q58388992-215DCFC1-6E7D-46BE-8396-19798D8B00F9
P2860
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@ast
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@en
type
label
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@ast
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@en
prefLabel
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@ast
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@en
P2860
P1476
The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
@en
P2093
Hideki Nakashima
Nobutaka Fujii
P2860
P304
P356
10.1517/13543784.12.2.185
P407
P577
2003-02-01T00:00:00Z